A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer â the FALUCA study
Lu, Shun, Chen, Gongyan, Sun, Yuping, Sun, Sanyuan, Chang, Jianhua, Yao, Yu, Chen, Zhendong, Ye, Feng, Lu, Junguo, Shi, Jianhua, He, Jianxing, Liu, Xiaoqing, Zhang, Yiping, Liu, Zhihua, Fang, Jian, ChJournal:
Lung Cancer
DOI:
10.1016/j.lungcan.2020.06.016
Date:
June, 2020
File:
PDF, 3.39 MB
2020